Track ZimVie Inc. Common Stock — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

ZimVie Inc. Common Stock ZIMV · Stock Open ZimVie Inc. Common Stock in new tab

18.99 USD
EPS
-0.69
P/B
1.30
ROE
-4.76
Beta
2.06
Loading chart...
Key Metrics
Earnings dateFeb. 25, 2026
EPS-0.69
Book Value14.64
Price to Book1.30
Debt/Equity56.82
% Insiders2.728%
Growth
Revenue Growth0.00%
Estimates
Forward P/E20.18
Forward EPS0.66

DCF Valuation

Tweak assumptions to recompute fair value for ZimVie Inc. Common Stock (ZIMV)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

ZimVie Inc. Common Stock Logo ZimVie Inc. Common Stock Analysis (ZIMV)

United States Health Care Official Website Stock

Is ZimVie Inc. Common Stock a good investment? ZimVie Inc. Common Stock (ZIMV) is currently trading at 18.99 USD.

Earnings Schedule: ZimVie Inc. Common Stock is expected to release its next earnings report on Feb. 25, 2026. The market consensus estimate for Forward EPS is 0.66.

Investor FAQ

Does ZimVie Inc. Common Stock pay a dividend?

No, it does not currently pay a dividend.

What asset class is ZimVie Inc. Common Stock?

ZimVie Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Feb. 25, 2026. The company currently has a trailing EPS of -0.69.

Company Profile

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to support dental tooth replacement and restoration procedures worldwide. The company offers dental implant systems and biomaterials; digital dentistry solutions; restorative and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; intraoral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including dental service organizations, as well as educational, medical and governmental entities, hospitals, and surgery centers through sales representatives, independent sales agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Palm Beach Gardens, Florida. As of October 20, 2025, ZimVie Inc. was taken private.

Exchange Ticker
NMS (United States) ZIMV
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion